Literature DB >> 24725204

Asthma control assessment in a pediatric population: comparison between GINA/NAEPP guidelines, Childhood Asthma Control Test (C-ACT), and physician's rating.

A Deschildre1, I Pin, K El Abd, S Belmin-Larrar, S El Mourad, C Thumerelle, P Le Roux, C Langlois, J de Blic.   

Abstract

BACKGROUND: Guidelines recommend regular assessment of asthma control. The Childhood Asthma Control Test (C-ACT) is a clinically validated tool. AIM: To evaluate asthma control according to GINA2006, NAEPP, pediatrician's assessment (PA), and C-ACT in asthmatic children visiting their ambulatory pediatrician or tertiary care pediatric pulmonologist.
METHODS: Demographic data, treatment, and number of severe exacerbations during the previous year were collected. Control was assessed using (i) strict GINA 2006 criteria, (ii) GINA without taking into account the exacerbation item, (iii) NAEPP criteria, and (iv) PA. Children and parents filled out the C-ACT.
RESULTS: Five hundred and twenty-five children completed the survey (mean age: 7.7 years; 28% ≤ 6 years). 78% had a controller treatment. 58% reported ≥ 1 severe exacerbation. C-ACT was ≤ 19 in 29.5%. Control was not achieved in 76.5%, 55%, 40%, and 34% according to GINA 2006 guidelines, NAEPP guidelines, GINA 2006 without exacerbation criteria, and PA, respectively. C-ACT was significantly lower in children ≤ 6 years old (P = 0.002) or with severe exacerbations (P < 0.0001). According to PA, 89% of patients with a C-ACT > 21 were controlled and 85% of patients with a C-ACT < 17 not controlled.
CONCLUSION: We observed discrepancies between the different tools applied to assess asthma control in children, and the impact of age and exacerbations. Cutoff point of 19 of C-ACT was not associated with the best performance compared to PA. Assessment of control should take into account symptoms and lung function as suggested by the latest GINA guidelines as well as exacerbation over a long period.
© 2014 John Wiley & Sons A/S. Published by John Wiley & Sons Ltd.

Entities:  

Keywords:  C-ACT; asthma; child; exacerbation; guidelines

Mesh:

Year:  2014        PMID: 24725204     DOI: 10.1111/all.12402

Source DB:  PubMed          Journal:  Allergy        ISSN: 0105-4538            Impact factor:   13.146


  7 in total

1.  Determining the Best Tool Comparable with Global Initiative for Asthma Criteria for Assessing Pediatric Asthma Control.

Authors:  Ayşegül Akan; Emine Dibek Mısırlıoğlu; Ersoy Civelek; Can Naci Kocabaş
Journal:  Pediatr Allergy Immunol Pulmonol       Date:  2021-08-24       Impact factor: 0.885

2.  Prospective observational cohort study of symptom control prediction in paediatric asthma by using the Royal College of Physicians three questions.

Authors:  Glen Andrews; David K H Lo; Matthew Richardson; Andrew Wilson; Erol A Gaillard
Journal:  NPJ Prim Care Respir Med       Date:  2018-10-24       Impact factor: 2.871

3.  Pragmatic Markers in the Management of Asthma: A Real-World-Based Approach.

Authors:  Giorgio Ciprandi; Gian Luigi Marseglia; Fabio Luigi Massimo Ricciardolo; Maria Angela Tosca
Journal:  Children (Basel)       Date:  2020-05-18

Review 4.  Update on Long-Acting Anticholinergics in Children and Adolescents With Difficult and Severe Asthma.

Authors:  Francesca Santamaria; Carla Ziello; Paola Lorello; Cristina Bouchè; Melissa Borrelli
Journal:  Front Pediatr       Date:  2022-07-19       Impact factor: 3.569

5.  The Usefulness of the Forced Oscillation Technique in the Diagnosis of Bronchial Asthma in Children.

Authors:  L Starczewska-Dymek; A Bozek; M Jakalski
Journal:  Can Respir J       Date:  2018-07-24       Impact factor: 2.409

6.  Cross-sectional study assessing the performance of the Arabic translated childhood asthma control test.

Authors:  Majid AlTeneiji; Alia AlKalbani; Huda Nasser; Durdana Iram; Afaf Alblooshi; Hassib Narchi
Journal:  NPJ Prim Care Respir Med       Date:  2018-11-01       Impact factor: 2.871

7.  Heterogeneity of Childhood Asthma in Korea: Cluster Analysis of the Korean Childhood Asthma Study Cohort.

Authors:  Jisun Yoon; Eun Jin Eom; Jin Tack Kim; Dae Hyun Lim; Woo Kyung Kim; Dae Jin Song; Young Yoo; Dong In Suh; Hey Sung Baek; Meeyong Shin; Ji Won Kwon; Gwang Cheon Jang; Hyeon Jong Yang; Eun Lee; Hwan Soo Kim; Ju Hee Seo; Sung Il Woo; Hyung Young Kim; Youn Ho Shin; Ju Suk Lee; Sungsu Jung; Minkyu Han; Jinho Yu
Journal:  Allergy Asthma Immunol Res       Date:  2021-01       Impact factor: 5.764

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.